FI844398L - Farmaceutiska kompositioner effektiva mot bukspottskoertelinflammation. - Google Patents

Farmaceutiska kompositioner effektiva mot bukspottskoertelinflammation.

Info

Publication number
FI844398L
FI844398L FI844398A FI844398A FI844398L FI 844398 L FI844398 L FI 844398L FI 844398 A FI844398 A FI 844398A FI 844398 A FI844398 A FI 844398A FI 844398 L FI844398 L FI 844398L
Authority
FI
Finland
Prior art keywords
pct
bukspottskoertelinflammation
mot
pharmaceutical composition
composition effective
Prior art date
Application number
FI844398A
Other languages
English (en)
Other versions
FI844398A7 (fi
FI844398A0 (fi
Inventor
Laszlo Madi-Szabo
Margit Morvai
Eva Horvath
Sandor Jancso
Piroska Tamasi
Istvan Kovacs
Ilona Maria Kiss
Gyoergy Bacsa
Maria Kubala
Magdolna Bene
Original Assignee
Biogal Gyogyszergyar
Alkaloida Vegyeszeti Gyar
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biogal Gyogyszergyar, Alkaloida Vegyeszeti Gyar filed Critical Biogal Gyogyszergyar
Publication of FI844398A7 publication Critical patent/FI844398A7/fi
Publication of FI844398L publication Critical patent/FI844398L/fi
Publication of FI844398A0 publication Critical patent/FI844398A0/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/53—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
FI844398A 1983-03-11 1984-03-12 Farmaceutiska kompositioner effektiva mot bukspottskoertelinflammation. FI844398A0 (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
HU83842A HU190072B (en) 1983-03-11 1983-03-11 Process for production of medical preparatives with sinergetic influence
PCT/HU1984/000016 WO1984003442A1 (en) 1983-03-11 1984-03-12 Pharmaceutical compositions of anti-pancreatic inflammatory effect

Publications (3)

Publication Number Publication Date
FI844398A7 FI844398A7 (fi) 1984-11-08
FI844398L true FI844398L (fi) 1984-11-08
FI844398A0 FI844398A0 (fi) 1984-11-08

Family

ID=10951646

Family Applications (1)

Application Number Title Priority Date Filing Date
FI844398A FI844398A0 (fi) 1983-03-11 1984-03-12 Farmaceutiska kompositioner effektiva mot bukspottskoertelinflammation.

Country Status (11)

Country Link
US (1) US4705779A (fi)
EP (1) EP0137832B1 (fi)
JP (1) JPS60500866A (fi)
AT (1) ATE28794T1 (fi)
AU (1) AU563697B2 (fi)
DE (1) DE3465250D1 (fi)
DK (1) DK536284A (fi)
FI (1) FI844398A0 (fi)
HU (1) HU190072B (fi)
RO (1) RO92632B (fi)
WO (1) WO1984003442A1 (fi)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19962924A1 (de) * 1999-12-24 2001-07-05 Bayer Ag Substituierte Oxazolidinone und ihre Verwendung
DE10129725A1 (de) * 2001-06-20 2003-01-02 Bayer Ag Kombinationstherapie substituierter Oxazolidinone
DE10300111A1 (de) * 2003-01-07 2004-07-15 Bayer Healthcare Ag Verfahren zur Herstellung von 5-Chlor-N-({(5S)-2-oxo-3-[4-(3-oxo-4-morpholinyl)-phenyl]-1,3-oxazolidin-5-yl}-methyl)-2-thiophencarboxamid
DE10355461A1 (de) 2003-11-27 2005-06-23 Bayer Healthcare Ag Verfahren zur Herstellung einer festen, oral applizierbaren pharmazeutischen Zusammensetzung
DE102004062475A1 (de) * 2004-12-24 2006-07-06 Bayer Healthcare Ag Feste, oral applizierbare pharmazeutische Darreichungsformen mit modifizierter Freisetzung
EP1685841A1 (en) * 2005-01-31 2006-08-02 Bayer Health Care Aktiengesellschaft Prevention and treatment of thromboembolic disorders
DE102005045518A1 (de) * 2005-09-23 2007-03-29 Bayer Healthcare Ag 2-Aminoethoxyessigsäure-Derivate und ihre Verwendung
DE102005047561A1 (de) 2005-10-04 2007-04-05 Bayer Healthcare Ag Feste, oral applizierbare pharmazeutische Darreichungsformen mit schneller Wirkstofffreisetzung
DK1934208T3 (da) 2005-10-04 2011-07-18 Bayer Schering Pharma Ag Ny polymorf form af 5-chlor-N-({(5S)-2-0x0-3-[4-(3-oxo-4-morpholinyl)-phenyl]-1,3-oxazolidin-5-yl}-methyl)-2-thiophencarboxamid
DE102005047558A1 (de) * 2005-10-04 2008-02-07 Bayer Healthcare Ag Kombinationstherapie substituierter Oxazolidinone zur Prophylaxe und Behandlung von cerebralen Durchblutungsstörungen
DE102006051625A1 (de) * 2006-11-02 2008-05-08 Bayer Materialscience Ag Kombinationstherapie substituierter Oxazolidinone

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR917M (fi) * 1961-02-10 1961-11-06
FR1611M (fr) * 1961-11-07 1962-12-17 Maurice Wahl Nouveau médicament, pour le traitement des congestions inflammatoires, en particulier des reins.
CH487171A (de) * 1963-10-22 1970-03-15 Siegfried Ag Verfahren zur Herstellung therapeutisch wirksamer 1,2-Dihydro-1,2,4-benztriazine
FR2128207B1 (fi) * 1971-03-11 1974-08-02 Zyma Sa
GB1589294A (en) * 1976-09-08 1981-05-13 Inverni Della Beffa Spa Pharmaceutical compositions containing anthocyanidines
CA1100237A (en) * 1977-03-23 1981-04-28 Roger F.W. Pease Multiple electron beam exposure system
CH639557A5 (en) * 1978-03-01 1983-11-30 Inverni Della Beffa Spa Pharmaceutical preparations
FR2437838A1 (fr) * 1978-07-25 1980-04-30 Roecar Holdings Nv Medicament pour le traitement de l'adenome benin de la prostate
EP0028660B1 (de) * 1979-11-10 1985-10-23 Siegfried Aktiengesellschaft Xanthinoxydasehemmer und Verwendung von Benztriazinderivaten
US4325949A (en) * 1980-02-15 1982-04-20 American Cyanamid Company Combinations of agents which give enhanced anti-inflammatory activity
DE3047487A1 (de) * 1980-12-17 1982-07-08 Continental Pharma S.A., Bruxelles "pharmazeutische zubereitung zur behandlung von degenerativen erkrankungen der gelenkknorpel und verfahren zu ihrer verwendung"

Also Published As

Publication number Publication date
HUT35520A (en) 1985-07-29
WO1984003442A1 (en) 1984-09-13
EP0137832A1 (en) 1985-04-24
RO92632A (ro) 1987-10-30
HU190072B (en) 1986-08-28
RO92632B (ro) 1987-10-31
AU2696584A (en) 1984-09-28
DE3465250D1 (en) 1987-09-17
ATE28794T1 (de) 1987-08-15
JPS60500866A (ja) 1985-06-06
FI844398A7 (fi) 1984-11-08
US4705779A (en) 1987-11-10
DK536284D0 (da) 1984-11-09
EP0137832B1 (en) 1987-08-12
FI844398A0 (fi) 1984-11-08
AU563697B2 (en) 1987-07-16
DK536284A (da) 1984-11-09

Similar Documents

Publication Publication Date Title
JO1552B1 (en) New pyridizinamine derivatives
ES8507535A1 (es) Acidos 7-amino-1-ciclopropil-6,8-difluor-1,4-dihidro-4-oxo-quinolincarboxilicos
HUT77627A (hu) 2,2-Diklór-alkánkarbonsavak, eljárás előállításukra és ezeket tartalmazó, inzulinrezisztencia kezelésére alkalmazható gyógyszerkészítmények
FI844398L (fi) Farmaceutiska kompositioner effektiva mot bukspottskoertelinflammation.
PT77898A (en) Process for the preparation of substituted 4-amino-methylenochromanes and 4-aminomethylenecromenes acting on the blood circulation and application thereof in the preparation of pharmaceutical compositions acting on the blood circulation
CA2002859A1 (en) Method of treating epithelial disorders
SE8204237L (sv) Karbostyrilforeningar, kompositioner innehallande dessa samt forfaranden for framstellning derav
JPS5547657A (en) Fluorine contained 1*44dihydropyridine compound and medical use
IT7948347A0 (it) Preparazione perfezionamento nelle composizioni anti-virali particolarmente per il trattamento di infezioni rinovirali e procedimento per la loro
ES8609312A1 (es) Procedimiento para la preparacion de silibinina exenta de isosilibina
FI874166A0 (fi) Anvaendning av 2',3'-dideoxicytidin -2'-en foer behandling av patienter infekterade med retrovirus.
DE3361990D1 (en) Alkylene-bridged guanidino-thiazole derivatives, method for their preparation and their use as medicaments
PT96585A (pt) Processo para prparacao de uma composicao microbiocida para tratamento de telhas de betao
BR8403770A (pt) Concentrado,composicao de tratamento de materiais do solo e processo para o tratamento de materiais do solo
DE3165050D1 (en) Salt of furosemide or piretanide as acid component and penbutolol as base component and pharmaceutical composition containing both of the said components
IT8320920A0 (it) Derivati di cicloalcani, procedimento per la loro preparazione e composizioni che licontengono.
ATE193206T1 (de) Zusammensetzung zur behandlung oder vorbeugung von herpes
DE3465014D1 (en) Podophyllotoxin preparations for use in the treatment of genital warts
BR8404467A (pt) Composicoes herbicidas,aplicacao e processo de preparacao de composicoes
IT8219650A0 (it) Derivati dagli acidi alfa o beta mercaptopropionilammidoacetici, processo per la loro preparazione e composizioni terapeutiche che li comprendono come principio attivo.
HUT62474A (en) Process for producing veterinary composition with antiparasitic effect
ES8601200A1 (es) Un procedimiento para preparar compuestos de 3-(2-haloetil)-4-oxopirazolo-(5, 1-d)-1, 2, 3, 5-tetrazin-8-carboxamida
AR230923A1 (es) Procedimiento de fabricacion de composiciones pesticidas para el tratamiento de madera,dichas composiciones y procedimiento para la proteccion de materiales de madera
IT8120307A0 (it) Disposizione per il trattamento termico di pezzi d'opera.
AR240312A1 (es) Compuesto de 2-carboximetil-azetidina, procedimiento de preparacion y composicon para esterilizacion de anteras.

Legal Events

Date Code Title Description
FC Application refused

Owner name: BIOGAL GYOGYSZERGYAR RT.

Owner name: ALKALOIDA VEGYESZETI GYAR